Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis

Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis

US Patent 10239937 · Granted Mar 26, 2019

Estimated economic value: $212,787,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies to the C3D fragment of complement component 32022
Modulating the alternative complement pathway2022
Anti-C3d antibody conjugates and methods of detecting complement activation2021
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging2019
Antibody-siRNA conjugates and uses therefor2019
Modulating the alternative complement pathway2019
Antibodies to the C3d fragment of complement component 32017
Complement receptor 2 (CR2) targeting groups2017
Anti-C3d antibody conjugates and methods of detecting complement activation2016
Targeting complement factor H for treatment of diseases2015
Humaneered anti-factor B antibody2015
Modulating the alternative complement pathway2015